RLAY Q4 2022 Earnings — Relay Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

RLAYRelay Therapeutics, Inc.

$2B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$253,000-55.4% YoY

Gross Profit

-$64M-25167.6% margin

Operating Income

-$73M-28794.9% margin

Net Income

-$68M-26681.0% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

-26.5%

Cash Flow

Operating Cash Flow

-$57M

Free Cash Flow

-$59M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$1.1B

Total Liabilities

$150M

Stockholders' Equity

$950M

Cash & Equivalents

$999M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$253,000	$567,000	-55.4%
Gross Profit	-$64M	-$51M	-26.1%
Operating Income	-$73M	-$68M	-7.6%
Net Income	-$68M	-$67M	-0.1%